Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPharming Group N.V. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q4 2025 | 1 | $0.01 | $0.01 | $0.01 |
Pharming Group N.V. Earnings Date And Information
Pharming Group N.V. last posted its earnings results on Thursday, October 24th, 2024. The company reported $-0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.01 by $0.03. The company had revenue of 75.06 M for the quarter and had revenue of 245.32 M for the year. Pharming Group N.V. has generated $0 earnings per share over the last year ($-0.0145 diluted earnings per share) and currently has a price-to-earnings ratio of -35.06. Pharming Group N.V. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based on prior year's report dates.
Pharming Group N.V. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/28/2024 | Q3 2024 | -$0.00 | $76.93 M | $75.06 M | ||
| 06/28/2024 | Q2 2024 | -$0.00 | $71.94 M | $74.03 M | ||
| 03/29/2024 | Q1 2024 | -$0.02 | $55.46 M | |||
| 04/04/2024 | Q4 2023 | -$0.00 | $81.87 M | |||
| 09/30/2023 | Q3 2023 | $0.00 | $61.67 M | $66.66 M | ||
| 06/30/2023 | Q2 2023 | $0.00 | $53.23 M | $54.90 M | ||
| 03/31/2023 | Q1 2023 | -$0.02 | $42.54 M | |||
| 04/05/2023 | Q4 2022 | -$0.02 | $54.62 M | |||
| 09/29/2022 | Q3 2022 | $0.01 | $53.50 M | $54.24 M | ||
| 06/29/2022 | Q2 2022 | $0.02 | $51.99 M | $50.15 M | ||
| 03/30/2022 | Q1 2022 | $0.00 | $46.62 M | |||
| 04/06/2022 | Q4 2021 | $0.00 | $45.75 M | |||
| 08/09/2021 | Q3 2021 | -$0.00 | $49.44 M | |||
| 08/09/2021 | Q2 2021 | $0.01 | $66.93 M | $49.74 M | ||
| 03/30/2021 | Q1 2021 | $0.01 | $42.25 M | |||
| 04/07/2021 | Q4 2020 | $0.01 | $70.23 M | |||
| 09/29/2020 | Q3 2020 | $0.01 | $55.09 M | $58.52 M | ||
| 06/29/2020 | Q2 2020 | $0.01 | $55.92 M | $45.27 M | ||
| 03/30/2020 | Q1 2020 | $0.01 | $54.37 M | |||
| 12/30/2019 | Q4 2019 | $0.02 | $54.37 M |
Pharming Group N.V. Earnings: FAQ's
When is Pharming Group N.V.'s earnings date?
Pharming Group N.V. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates.
How can I listen to Pharming Group N.V.'s earnings conference
call?
The conference call for Pharming Group N.V.'s latest earnings report can be listened to online.
How can I read Pharming Group N.V.'s conference call transcript?
The conference call transcript for Pharming Group N.V.'s latest earnings report can be read online.
How much revenue does Pharming Group N.V. generate each year?
Pharming Group N.V. (:PHAR) has a recorded annual revenue of $245.32 M.
How much profit does Pharming Group N.V. generate each year?
Pharming Group N.V. (:PHAR) has a recorded net income of $245.32 M. Pharming Group N.V. has generated $-0.0145 earnings per share over the last four quarters.
What is Pharming Group N.V.'s price-to-earnings ratio?
Pharming Group N.V. (:PHAR) has a price-to-earnings ratio of -35.06 and price/earnings-to-growth ratio is 7.19.